PECAM1
Platelet endothelial cell adhesion molecule
Also known as: CD31, PECA1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P16284
- Gene
- PECAM1
- Ensembl
- ENSG00000261371
- Chromosome
- 17
- Canonical length
- 738 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoli,Plasma membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is found on the surface of platelets, monocytes, neutrophils, and some types of T-cells, and makes up a large portion of endothelial cell intercellular junctions. The encoded protein is a member of the immunoglobulin superfamily and is likely involved in leukocyte migration, angiogenesis, and integrin activation. [provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
738 residues, UniProt reviewed canonical sequence.
>P16284|PECAM1
1 MQPRWAQGAT MWLGVLLTLL LCSSLEGQEN SFTINSVDMK SLPDWTVQNG KNLTLQCFAD
61 VSTTSHVKPQ HQMLFYKDDV LFYNISSMKS TESYFIPEVR IYDSGTYKCT VIVNNKEKTT
121 AEYQVLVEGV PSPRVTLDKK EAIQGGIVRV NCSVPEEKAP IHFTIEKLEL NEKMVKLKRE
181 KNSRDQNFVI LEFPVEEQDR VLSFRCQARI ISGIHMQTSE STKSELVTVT ESFSTPKFHI
241 SPTGMIMEGA QLHIKCTIQV THLAQEFPEI IIQKDKAIVA HNRHGNKAVY SVMAMVEHSG
301 NYTCKVESSR ISKVSSIVVN ITELFSKPEL ESSFTHLDQG ERLNLSCSIP GAPPANFTIQ
361 KEDTIVSQTQ DFTKIASKSD SGTYICTAGI DKVVKKSNTV QIVVCEMLSQ PRISYDAQFE
421 VIKGQTIEVR CESISGTLPI SYQLLKTSKV LENSTKNSND PAVFKDNPTE DVEYQCVADN
481 CHSHAKMLSE VLRVKVIAPV DEVQISILSS KVVESGEDIV LQCAVNEGSG PITYKFYREK
541 EGKPFYQMTS NATQAFWTKQ KASKEQEGEY YCTAFNRANH ASSVPRSKIL TVRVILAPWK
601 KGLIAVVIIG VIIALLIIAA KCYFLRKAKA KQMPVEMSRP AVPLLNSNNE KMSDPNMEAN
661 SHYGHNDDVR NHAMKPINDN KEPLNSDVQY TEVQVSSAES HKDLGKKDTE TVYSEVRKAV
721 PDAVESRYSR TEGSLDGTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PECAM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 427 nTPM
Expression across tissuesHPA
Tissue
- placenta: 427 nTPM
- lung: 193 nTPM
- adipose tissue: 170 nTPM
- breast: 117 nTPM
- tongue: 90 nTPM
- spleen: 89 nTPM
Single-cell type
- vascular endothelial cells: 1,148 nCPM
- neutrophils: 525 nCPM
- platelets: 486 nCPM
- lymphatic endothelial cells: 440 nCPM
- monocytes: 284 nCPM
- monocyte progenitors: 217 nCPM
Immune cell
- non-classical monocyte: 706 nTPM
- intermediate monocyte: 420 nTPM
- neutrophil: 394 nTPM
- classical monocyte: 264 nTPM
- total PBMC: 224 nTPM
- eosinophil: 220 nTPM
Brain region
- thalamus: 42 nTPM
- spinal cord: 38 nTPM
- medulla oblongata: 34 nTPM
- pons: 33 nTPM
- midbrain: 31 nTPM
- hypothalamus: 29 nTPM
ReferencesPubMed · IEDB
Publications for PECAM1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- B lymphocytes enhance interferon-α production by plasmacytoid dendritic cells.
2012 · Arthritis Rheum · RCR 1.3 · 50 citations - MIB-1 immunoreactivity correlates with blood vessel density and survival in disseminated malignant melanoma.
1999 · Oncology · RCR 0.3 · 14 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
OntologyGO
Biological processes
- angiogenesis
- bicellular tight junction assembly
- cell recognition
- cell surface receptor signaling pathway
- cell-cell adhesion
- cell-cell adhesion via plasma-membrane adhesion molecules
- cellular response to mechanical stimulus
- detection of mechanical stimulus
- diapedesis
- endothelial cell migration
- endothelial cell morphogenesis
- endothelial cell-matrix adhesion
- establishment of endothelial barrier
- glomerular endothelium development
- homophilic cell adhesion via plasma membrane adhesion molecules
- immune response
- leukocyte cell-cell adhesion
- maintenance of blood-brain barrier
- monocyte extravasation
- neutrophil extravasation
- phagocytosis
- positive regulation of cell migration
- positive regulation of intracellular signal transduction
- positive regulation of MAPK cascade
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of protein localization to cell-cell junction
- Rho protein signal transduction
- signal transduction
- vasodilation
- wound healing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PECAM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PECAM1 as an antibody target. Whether an autoantibody or antibody against PECAM1 could matter depends on whether native PECAM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PECAM1 is annotated at the cell surface, where native PECAM1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PECAM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...